Q-Line Biotech are expected to make strong stock market debut on Friday, with grey market trends indicating robust investor demand ahead of listing. According to market trackers, the company’s shares were commanding a grey market premium (GMP) of around 36% ahead of listing on the NSE SME platform.
Based on the final issue price of Rs 343 per share, the GMP implies a likely listing price of around Rs 466 in the unofficial market. The Rs 214 crore IPO had opened for subscription between May 21 and May 25, while the allotment was finalised on May 26.
